Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current concepts in multimodality therapy for retroperitoneal sarcoma.

Matthew H G Katz1, Eugene A Choi, Raphael E Pollock

  • 1The University of Texas, MD Anderson Cancer Center, Department of Surgical Oncology, Houston, TX 77030, USA. mhgkatz@mdanderson.org

Expert Review of Anticancer Therapy
|February 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional study.

Journal of the National Cancer Institute·2026
Same author

Robotic Transmesocolic Approach to the Left Retroperitoneum.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: Longitudinal Symptom Recovery After Pancreatectomy-A Prospective Patient-Reported Outcomes Study using MDASI.

Annals of surgical oncology·2026
Same author

Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study.

The British journal of surgery·2026
Same author

5x-Multiplier Versus 3-Tier Model: A Pragmatic Randomized Clinical Trial for Discharge Opioid Prescriptions After Intra-Abdominal Cancer Surgery.

Annals of surgery·2026
Same author

Aerobic Exercise Activates S1PR1 Signaling in Tumor Endothelial Cells to Promote Vascular Function in Pancreatic Cancer.

Cancer research·2026
Same journal

Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.

Expert review of anticancer therapy·2026
Same journal

Barriers to the use of brachytherapy for treatment of cervical cancer and prostate cancer in low- and middle-income countries.

Expert review of anticancer therapy·2026
Same journal

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

Expert review of anticancer therapy·2026
Same journal

Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategies.

Expert review of anticancer therapy·2026
Same journal

RTsDEN: reverse task attention enabled deep learning model for lung cancer detection using computed tomography.

Expert review of anticancer therapy·2026
Same journal

The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinoma.

Expert review of anticancer therapy·2026
See all related articles

Radical surgery is the best treatment for retroperitoneal sarcoma but often leads to recurrence. Adjuvant therapies like radiation and chemotherapy show promise but need more study due to the disease

Area of Science:

  • Surgical Oncology
  • Medical Oncology
  • Radiation Oncology

Background:

  • Retroperitoneal sarcoma is rare, making research challenging.
  • Radical surgical resection is the primary treatment, but locoregional recurrence is common.
  • Adjuvant therapies are being explored to improve outcomes.

Purpose of the Study:

  • To review current literature on retroperitoneal sarcoma diagnosis, staging, and treatment.
  • To highlight the need for large, multi-institutional studies.

Main Methods:

  • Literature review of diagnosis, staging, and treatment strategies.
  • Analysis of current adjuvant therapy approaches (radiation, chemotherapy).

Main Results:

Related Experiment Videos

  • Radical surgery is effective but associated with high recurrence rates.
  • Adjuvant radiation and chemotherapy show promising results in improving local control and survival.
  • The rarity of retroperitoneal sarcoma limits large-scale prospective studies.

    • Conclusions:

    • Despite challenges, adjuvant strategies offer potential benefits for retroperitoneal sarcoma patients.
    • Further large, multi-institutional studies are critical to establish optimal treatment protocols.
    • Advancing knowledge in retroperitoneal sarcoma requires collaborative research efforts.